Frost & Sullivan Published the 2025 Blue Book on the Current Status and Trends of Global Expansion of Chinese Medical Devices

Core Insights - The "2025 Blue Book on the Current Status and Trends of Global Expansion of Chinese Medical Devices" provides a comprehensive analysis of the Chinese medical device industry's growth, challenges, and opportunities in global markets [1][6]. Group 1: Market Overview - China's medical device market size increased from 729.8 billion RMB in 2020 to 941.7 billion RMB in 2024, reflecting a CAGR of 6.6% [1]. - The global medical device market grew from 456.6 billion USD to 623.0 billion USD during the same period, achieving a CAGR of 8.1% [2]. Group 2: Drivers of Global Expansion - Internal factors driving the global expansion of Chinese medical device companies include intense domestic competition, centralized procurement policies leading to price pressures, and improvements in R&D and innovation capabilities [3]. - External factors include a broad global market for medical devices, price competitiveness of Chinese products, and the rising global influence of China [3]. Group 3: Historical Context and Trends - Early Chinese medical device companies focused on basic healthcare segments, leveraging cost advantages to export low-value consumables post-WTO accession in 2001 [4]. - The pandemic accelerated globalization for companies in molecular diagnostics, with a shift towards mid-high-end markets to enhance competitiveness by 2023 [4]. Group 4: Value Chain and Strategies - The medical device value chain encompasses R&D, manufacturing, distribution, and sales, forming a global ecosystem that enhances market reach and patient impact [5]. - Strategies for global expansion include various distribution models, overseas manufacturing, and mergers and acquisitions, with case studies illustrating successful paths [8]. Group 5: Sub-sector and Regional Analysis - The Blue Book includes a sub-sector analysis covering life support equipment, medical imaging, vascular intervention products, and more, assessing their current states and prospects [8]. - Regional analysis addresses the macroeconomics, medical insurance systems, and regulatory requirements in key markets such as the U.S., EU, Japan, and regions involved in the Belt and Road Initiative [8]. Group 6: Challenges and Solutions - Key difficulties in global expansion include unclear direction, inaccurate market assessments, and a lack of understanding of market access procedures [8]. - Solutions involve increased R&D investment, alignment with international standards, and improved cross-cultural communication [8].